AstraZeneca

UK under 30s to be offered alternative to AstraZeneca vaccine over blood clot risks

Four people in a million risk blood clots after getting the jab

3 min read

The European Medicines Agency review has concluded that there’s no evidence so far that the AstraZeneca vaccine has caused increased incidents of blood clotting

‘No indication’ AstraZeneca vaccine causes blood clots, says EU medicines regulator

The EU’s review of the vaccine is still an ‘ongoing process’, the EMA’s executive director said

3 min read

Nurse Susann Rettberg handles a syringe of AstraZeneca Covid-19 vaccine in Saxony during the coronavirus pandemic on March 15, 2021 in Dippoldiswalde, Germany.

Explainer: Why Germany, France and now Italy are refusing to use AstraZeneca’s Covid vaccine

Reports of dangerous blood clots in recently vaccinated patients has some countries scared about using the shot

4 min read

Dental hygienist and Covid vaccinator, Petra Moinar, prepares syringes with the AstraZeneca vaccine before it is administered at Battersea Arts Centre

AstraZeneca defends vaccine after Netherlands and Republic of Ireland join countries quitting jab

Pharma said studies showed its jab presented ‘no increased risk’ of blood clots

2 min read

AstraZeneca plans to roll out variant-resistant vaccine this autumn

The company is working with the University of Oxford to roll out the new vaccine

2 min read

A member of the military vaccinates a man at the COVID-19 mass vaccination centre at Pentwyn Leisure Centre in Cardiff, Wales

Scientists start UK study for mix-and-match regime for Covid jabs

Deputy chief medical officer Jonathan Van Tam said it’s possible that a differentiated-dosing regimen could provide even greater protection

2 min read

A vaccination centre in Newbridge, Wales

Decline in Covid spread evident for the first time, study of Oxford vaccine shows

The news means vaccinating people could also result in indirectly protecting others from getting the disease too

Doses of the Oxford University-AstraZeneca Covid-19 vaccine arrive at the Princess Royal Hospital in Haywards Heath. Two London NHS trusts are among the six to start delivering the vaccine this week, as well as trusts in Sussex, Oxford and Lancashire and Warwickshire

Lockdown looms to combat virus as first Oxford-AstraZeneca shots given

An immediate national lockdown would ‘help maximise the effectiveness of the vaccines coming down the track’, scientists said

The UK government is rolling out the first doses as of 30 December, to the most vulnerable in its high-risk priority groups including care home residents and staff, people over 80 and health and care workers, then to the rest of the population in order of age and risk, including those who are clinically extremely vulnerable

Here’s what’s next for UK vaccine schedule after green light for Oxford-AstraZeneca shot

Here's what the government is planning, when roll out will begin and who can get the shot first

Oxford-AstraZeneca's vaccine has been approved for use in the UK, with the first doses rolled out today, the UK government said in a joint statement with the firm. The announcement comes as Covid-19 cases surge past the first peak of infections seen during the first wave of the pandemic in April.

Oxford-AstraZeneca vaccine gets UK approval for immediate rollout as new variant takes hold

Individuals that are vaccinated will receive their second dose within 12 weeks of the first

British drug giant AstraZeneca’s $38.8bn bid for Boston-based pharmaceutical company Alexion pushed deal values to $1tn in the fourth quarter

AstraZeneca-Alexion deal pushes global M&A over the $1tn mark for second consecutive quarter

The deal between AstraZeneca and Alexion comes amid a slew of M&A megadeals. Deals recorded since July total $2.1tn, according to Refinitiv data

1 min read

AstraZeneca exec pushes back on questions over dosing error for Covid-19 vaccine

US officials said the data is further proof that vaccines can prevent Covid-19, but they also cautioned that the 90% effectiveness rate might not hold up under further analysis

4 min read

This pharma short seller says AstraZeneca woes show vaccine hype misplaced

'This is a reminder that these vaccines are highly experimental,' says Barry Norris, chief executive of Argonaut Capital, and manager of the Argonaut Absolute Return Fund

2 min read